Charged by both the SEC and DOJ with violating the FCPA, Indiana-based medical device company Biomet, Inc. (“Biomet”) agreed to pay more than $22 million to settle the charges. The charges arose from SEC and DOJ’s ongoing global investigation into medical device companies bribing publicly-employed physicians. Although the company’s common stock is no longer publicly… Continue Reading
Monthly Archives: March 2012
Monthly China Anti-Bribery Update Report– February 2012
Posted in China, China enforcement actionsThe following monthly update on developments in the People’s Republic of China’s (“PRC”) antibribery laws, regulations and government enforcement actions is brought to you with the assistance of our colleagues in Squire Sanders’ Shanghai Office. Enforcement Actions (1) On February 8, 2012, Chen Meng (“Chen”), former chief deputy official of Putuo District, Shanghai, went on… Continue Reading